Spoken Alpha
Aspira Women's Health Inc.
Aspira Women's Health Inc. develops and operates AI-powered blood tests to aid in the diagnosis of gynecologic diseases, primarily ovarian cancer and endometriosis.
Aspira Women's Health Inc is a Healthcare company operating in Diagnostics & Research with a $13.5M market cap.
Most recent reported earnings: Q1 FY2026 (May 28, 2026).
Behavioral analysis
Disclosures
Extracted from Unknown source, 2026-08-30.
Transcripts
We index calls for roughly 3,000 US-listed companies. If you'd like us to add AWHL, reply to your welcome email and we'll prioritize it.
History
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
Peers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for AWHL.
$ curl https://api.spokenalpha.com/v1/companies/AWHLFAQ
Spoken Alpha indexes AWHL's earnings call transcripts at https://spokenalpha.com/companies/AWHL. Each call links to attributed speakers and parsed analyst Q&A. Aspira Women's Health Inc.'s own investor relations page is at https://ir.aspirawh.com/.
Aspira Women's Health Inc. (AWHL) operates in the Healthcare sector (Diagnostics & Research industry).
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q1 FY2026 | 2026-05-28 | $-0.05 | — | — | $2.0M | — | — | EODHD |
| Q3 FY2025 | 2025-11-13 | $-0.13 | $-0.21 | +38.1% | $2.3M | — | — | EODHD |
| Q2 FY2025 | 2025-08-12 | $-0.07 | $-0.22 | +68.2% | $2.4M | — | — | EODHD |
| Q1 FY2025 | 2025-05-18 | $-0.09 | $-0.22 | +59.1% | $2.3M | — | — | EODHD |
| Q4 FY2024 | 2025-03-26 | $-0.08 | $-0.22 | +63.6% | $2.3M | — | — | EODHD |
| Q3 FY2024 | 2024-11-18 | $-0.23 | $-0.30 | +23.3% | $2.3M | — | — | EODHD |
| Q2 FY2024 | 2024-08-11 | $-0.28 | $-0.33 | +15.2% | $2.4M | — | — | EODHD |
| Q1 FY2024 | 2024-05-14 | $-0.38 | $-0.32 | -18.8% | $2.2M | — | — | EODHD |
| Q4 FY2023 | 2024-03-27 | $-0.30 | — | — | $2.1M | — | — | EODHD |
| Q3 FY2023 | 2023-11-12 | $-0.44 | $-0.40 | -10.0% | — | — | — | EODHD |
| Q2 FY2023 | 2023-08-13 | $-0.22 | $-0.44 | +50.0% | — | — | — | EODHD |
| Q1 FY2023 | 2023-05-10 | $-0.73 | $-0.06 | -100.0% | — | — | — | EODHD |
| Q4 FY2022 | 2023-03-21 | $-0.53 | $-1.05 | +49.5% | — | — | — | EODHD |
| Q3 FY2022 | 2022-11-09 | $-0.60 | $-1.05 | +42.9% | — | — | — | EODHD |
| Q2 FY2022 | 2022-08-09 | $-1.05 | $-1.05 | 0.0% | — | — | — | EODHD |
| Q1 FY2022 | 2022-05-10 | $-1.20 | $-1.05 | -14.3% | — | — | — | EODHD |
| Q4 FY2021 | 2022-03-22 | $-1.20 | $-0.08 | -100.0% | — | — | — | EODHD |
| Q3 FY2021 | 2021-11-09 | $-1.14 | $-0.75 | -52.0% | — | — | — | EODHD |
| Q2 FY2021 | 2021-08-11 | $-0.78 | $-0.75 | -4.0% | — | — | — | EODHD |
| Q1 FY2021 | 2021-05-12 | $-0.75 | $-2.60 | +71.2% | — | — | — | EODHD |
Source: EODHD. AWHL reported actuals as published; sparse fields render as —.